Your browser doesn't support javascript.
loading
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up.
Abdallah, Nadine; Witzig, Thomas E; Kumar, Shaji K; Lacy, Martha Q; Hayman, Suzanne R; Dispenzieri, Angela; Roy, Vivek; Gertz, Morie A; Bergsagel, P Leif; Rajkumar, S Vincent.
Afiliação
  • Abdallah N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Witzig TE; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kumar SK; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Lacy MQ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hayman SR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Dispenzieri A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Roy V; Division of Hematology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Gertz MA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Bergsagel PL; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
  • Rajkumar SV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. rajkumar.vincent@mayo.edu.
Leukemia ; 38(5): 1169-1171, 2024 May.
Article em En | MEDLINE | ID: mdl-38418610
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article